145 related articles for article (PubMed ID: 15975819)
1. Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-beta 1.
Liu G; Zhang F; Lee J; Dong Z
Cytokine; 2005 Aug; 31(3):241-9. PubMed ID: 15975819
[TBL] [Abstract][Full Text] [Related]
2. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
3. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
Han SH; Yea SS; Jeon YJ; Yang KH; Kaminski NE
J Pharmacol Exp Ther; 1998 Dec; 287(3):1105-12. PubMed ID: 9864299
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
7. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta inhibits interleukin-10 synthesis by human monocytic cells.
Suberville S; Bellocq A; Peguillet I; Lantz O; Stordeur P; Fouqueray B; Baud L
Eur Cytokine Netw; 2001 Mar; 12(1):141-6. PubMed ID: 11282558
[TBL] [Abstract][Full Text] [Related]
10. Induction of human LTBP-3 promoter activity by TGF-beta1 is mediated by Smad3/4 and AP-1 binding elements.
Kantola AK; Keski-Oja J; Koli K
Gene; 2005 Dec; 363():142-50. PubMed ID: 16223572
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interleukin 8 expression in human malignant melanoma cells.
Singh RK; Varney ML
Cancer Res; 1998 Apr; 58(7):1532-7. PubMed ID: 9537260
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
19. Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation.
Janji B; Melchior C; Vallar L; Kieffer N
Oncogene; 2000 Jun; 19(27):3069-77. PubMed ID: 10871859
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reductase in cultured human mesangial cells.
Jiang T; Qu JJ; Nishinaka T; Zhang N
Nephrology (Carlton); 2008 Jun; 13(3):212-7. PubMed ID: 18315703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
